Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities

Advanced Certificate Program IV:

Home

Sign In

About

Curriculum

Library

Ask the Experts

Resources

Additional Information

Target Audience

Program Goal

Learning Objectives

CME/CE Information

CME/CE

Contract

Disclosures

Faculty

Roster

Disclosures

Technical Requirements

Update Profile

Contact Us

These independent CME /CE activities are supported by educational grants from

Bristol-Myers Squibb

Gilead Sciences, Inc.

Keep up to date with us via twitter!

Projects In Knowledge
Overlook at Great Notch
150 Clove Road
Little Falls, NJ 07424
Tel: (973) 890-8988
Fax: (973) 890-8866

Projects In Knowledge is pleased to present Advanced Certificate Program IV: Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities.

This year's state-of-the-science curriculum features the very latest information on screening and current and emerging treatment strategies for HBV management, including new guidelines from the CDC, AASLD, and Keeffe.

Courses are released continuously throughout the year, and all offer CME and CE credit.

You may also access the curricula from previous years on this website. Year 3 curriculum may be accessed through the search filter on the curriculum page. Curriculum from years 1 and 2 are available in the Library.

Co-Chairs:

	Adrian M. Di Bisceglie, MD, FACP Chairman, Internal Medicine Chief of Hepatology Saint Louis University School of Medicine St. Louis, Missouri

	Robert G. Gish, MD Medical Director Liver Transplant Program Chief, Division of Hepatology and Complex GI California Pacific Medical Center San Francisco, California

Program Features:

Timely and relevant information
CME credit and CE credit provided
E-mail notification when a new course becomes available
Periodic program updates, news, and announcements
Certificate of Advanced Study in Hepatitis B Management awarded upon completion of all 18 course posttests and evaluations

Learning Objectives:

Assess the importance of screening, diagnosis, and optimal treatment intervention of patients with or at risk of developing HBV through an understanding of the epidemiology, risk factors, and disease burden imposed by HBV, including cirrhosis, HCC, morbidity, and mortality.

Assess the impact of cultural differences on patient communication and management of HBV infection (comparing the Asian and Pacific Islander, Latino, African-American, and Caucasian communities) to bridge these differences and improve patient outcomes.

Assess the role of HBV DNA and other markers in determining when to treat and optimal treatment selection in HBV-infected patients with diverse ethnic backgrounds, and in evaluating on-treatment response to therapy to improve patient outcomes.

Evaluate the role of genotypes in determining prognosis and selection of treatment to provide HBV-infected patients with improved outcomes.

Integrate HBV vaccination intervention into prevention strategies to reduce the incidence and prevalence of HBV and improve patient outcomes.

Formulate anti-HBV treatment strategies, considering safety, efficacy, endpoints, and resistance patterns of currently available and emerging antiviral agents as well as cultural differences among patients, to improve response rates in patients with HBV infection.

Integrate prescribing and monitoring strategies to help prevent or reduce the emergence of resistance into individualized anti-HBV treatment plans for infected patients.

These independent CME/CE activities are supported by educational grants from Bristol-Myers Squibb and Gilead Sciences, Inc.

Special Announcement!

Projects In Knowledge poster presented
at DDW 2009

Physicians at the 2009 DDW Hepatitis B: Combined Poster Session visited Projects In Knowledge's poster, created in collaboration with Adrian Di Bisceglie, MD, FACP, and Robert Gish, MD, that addressed their proprietary survey findings and identified practice gaps clinicians want addressed in educational programs.

To access the poster PDF, click on the following link: www.projectsinknowledge.com/DDWposter

First EASL Clinical Practice Guidelines on the Management of Chronic Hepatitis B

In October 2008, the European Association for the Study of the Liver (EASL) published its first Clinical Practice Guidelines. The guidelines were developed to update existing guidelines for the optimal management of chronic hepatitis B.

To access the new guidelines, Click Here.

View Public Service Announcement
Video on HBV

In 2006, the Asian Pacific American Medical Student Association (APAMSA) enlisted two medical students to create a public service announcement urging the Asian Pacific American community to get screened and vaccinated for hepatitis B.

The result was a spoken word performance piece that has generated widespread acclaim for its innovation and effectiveness.
Click here to view this video.

Covered Topics Include

Screening for HBV (including new CDC guidelines)
AASLD, Keeffe, and APASL Hepatitis B virus Treatment Guidelines (including updates)
HBV virology and genotyping
Assessing At-Risk Individuals for HBV - Special Populations
Screening and Diagnosis in the Asian Community
Chronic HBV Disease Burden
HBV Treatment Options and Strategies
HBV Treatment Resistance - Detection and Management

Treatment Strategies Discussed

AASLD, Keeffe, and APASL HBV Treatment Guidelines
Treatments
- (Peg)interferon
- Oral Nucleosides/Nucleotides: Lamivudine, Adefovir, Entecavir, Telbivudine
- Investigational Drugs: Emtricitabine, Tenofovir, Clevudine
- Combination Therapy
Treatment Endpoints and Duration
Monitoring for Treatment Response

Take your knowledge to the next level with this highly engaging Certificate Program!

Hepatitis News powered by

About the Program